Thursday, 11 December 2025

USPTO Issues New Guidance on AI Assisted Inventions

›
The USPTO has rescinded its prior guidance on AI assisted inventions which relied on the Pannu factors when determining if a human sufficien...

Teva Pharmaceuticals will remove over 200 improper patent listings from the Orange Book

›
On December 10, 2025, the FTC announced that Teva Pharmaceuticals will “[r]emove. . .  Over 200 Improper Patent Listings” to improve generic...

The AI Genesis Mission Launched by Trump Administration

›
On November 24, the Trump Administration announced the Genesis Mission to improve scientific research.  The Press Release states: USHERING...
Tuesday, 25 November 2025

USPTO Stands Firm for Strong Patent Remedies

›
USPTO states that strong remedies for patent infringement are necessary to protect the public interest.  The Press Release states: The Uni...
Thursday, 23 October 2025

USPTO Director Reclaims Authority to Institute IPRs

›
The new Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, John Squires, h...
Monday, 13 October 2025

UK intervention on SEPs including rate setting swims against the tide

›
The UK Intellectual Property Office’s 2025 consultation on standard essential patents proposes measures to improve licensing transparency an...
Wednesday, 8 October 2025

U.S. NIST Report on DeepSeek

›
The U.S. National Institute of Standards and Technology has recently released a 69 page report concerning DeepSeek and the risks associated...

A Good Idea to Cut Public Funding for R&D? Doesn't Look Like It.

›
David Rotman has authored an excellent article titled, “How to Measure the Returns on R&D Spending: Forget the Glorious Successes of Pas...
Tuesday, 30 September 2025

Medicaid to Receive Most Favored Nation Pricing on Pfizer Drugs

›
The White House has announced that President Trump has made a deal with Pfizer for state Medicaid to receive most favored nation pricing on ...